Application and Pitfalls of Immunohistochemistry in Diagnosis of Challenging Genitourinary Cases.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32101059.
- Also identified by DOI 10.5858/arpa.2019-0550-RA.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Immunohistochemistry (IHC) has become increasingly important in the evaluation of pathologic conditions in the genitourinary (GU) organs. In addition to careful evaluation of hematoxylin-eosin sections and generation of a differential diagnosis, choosing the optimal panel of IHC markers becomes even more important when the biopsy material is very limited. The following summary of our experience supplemented with relevant literature review exemplifies how to use IHC to facilitate pathologic diagnosis in the GU system. To describe our experience with the most common immunohistochemical markers used in GU pathology. Institutional experience and literature search comprise our data sources. Application of IHC provides enormous benefits to the interpretation of GU pathologic conditions, including benign and malignant lesions. However, both insufficient and excessive types of use of IHC, as well as incorrect interpretations in common and rare GU conditions, could present pitfalls in diagnosis.
Medical subject headings
- Biomarkers, Tumor
- Immunohistochemistry
- Neoplasms, Germ Cell and Embryonal
- Prostatic Neoplasms
- Testicular Neoplasms
- Urogenital Neoplasms